RAPP MICHAEL
Insider CIK 1405685 · CCAC President and Chairman, Director · IMNM Director, 10% owner · ZYNE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMNM Immunome Inc. | A Award | 2023-10-02 | 2023-10-03 | 253,806 | $5.91 | $1.50M | 1,071,172 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| IMNM Immunome Inc. | A Award | 2023-01-15 | 2023-01-17 | 17,500 | $4.00 | $70.0K | 817,366 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-09-13 | 2021-09-14 | 25,962 | $19.96 | $518.2K | 208,742 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-09-10 | 2021-09-13 | 15,500 | $17.85 | $276.7K | 182,780 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-09-09 | 2021-09-13 | 8,170 | $17.44 | $142.5K | 145,000 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-09-09 | 2021-09-13 | 22,280 | $18.46 | $411.3K | 167,280 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-05-26 | 2021-05-26 | 2,300 | $18.94 | $43.6K | 136,830 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-05-25 | 2021-05-26 | 19,303 | $18.32 | $353.6K | 134,530 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-05-24 | 2021-05-26 | 31,895 | $18.38 | $586.2K | 115,227 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 555,554 | — | $0 | 0 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 166,666 | — | $0 | 166,666 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 166,666 | — | $0 | 0 | SEC↗ |
| IMNM Immunome Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 555,554 | — | $0 | 555,554 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2020-10-06 | 2020-10-08 | 83,332 | $12.00 | $1000.0K | 638,886 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-05-30 | 2018-05-31 | 5,885 | $10.45 | $61.5K | 1,500,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-05-02 | 2018-05-02 | 15,000 | $10.46 | $156.9K | 1,494,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-03-22 | 2018-03-23 | 10,000 | $9.28 | $92.8K | 1,479,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-01-02 | 2018-01-03 | 15,000 | $12.99 | $194.8K | 1,469,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-10-23 | 2017-10-23 | 25,745 | $9.94 | $255.9K | 1,454,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-10-20 | 2017-10-23 | 30,000 | $9.78 | $293.4K | 1,428,370 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-10-19 | 2017-10-23 | 44,255 | $9.59 | $424.4K | 1,398,370 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2016-12-29 | 2016-12-29 | 10,000 | $15.85 | $158.5K | 1,354,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | J Other | 2016-02-02 | 2016-02-16 | 80,467 | — | $0 | 1,344,115 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion deriv | 2015-08-10 | 2015-08-10 | 1,066,911 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion | 2015-08-10 | 2015-08-10 | 567,505 | — | $0 | 1,263,648 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | P Buy | 2013-10-16 | 2013-10-18 | 163,056 | $5.00 | $815.3K | 1,563,198 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | J Other | 2013-04-23 | 2013-04-25 | 75,750 | — | $0 | 1,685,699 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | J Other | 2013-04-23 | 2013-04-25 | 121,500 | — | $0 | 1,564,199 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | J Other | 2012-06-19 | 2012-06-20 | 93,250 | — | $0 | 1,761,449 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | J Other | 2012-06-19 | 2012-06-20 | 176,000 | — | $0 | 1,668,199 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | P Buy | 2012-03-01 | 2012-03-05 | 10,214 | — | $0 | 1,844,199 | SEC↗ |
| CCAC COMMITTED CAPITAL ACQUISIT | S Sale | 2012-03-01 | 2012-03-05 | 100,000 | — | $0 | 1,833,985 | SEC↗ |